In their study, a 1 mg/L increase in C-reactive protein (CRP) among 7178 patients with stable cardiovascular diseases was associated with an increased incidence of new cancer (HR 1.07, 95%CI 1.04–1.09), particularly for lung cancer (HR 1.16, 95%CI 1.10–1.22) [22]. This evidence concerns the gene CRP and cardiovascular disorder.